terazosin   Click here for help

GtoPdb Ligand ID: 7302

Synonyms: ABBOTT-45975 | Hytrin®
Approved drug
terazosin is an approved drug (FDA (1987))
Compound class: Synthetic organic
Comment: Postsynaptic α1-adrenoceptor inhibitor.
Marketed formulations may contain terazosin hydrochloride (PubChem CID 44383).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: terazosin

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 103.77
Molecular weight 387.19
XLogP 2.32
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1
Isomeric SMILES COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1
InChI InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
α1D-adrenoceptor Primary target of this compound Hs Antagonist Antagonist 7.7 – 9.1 pKi - 1-2
pKi 7.7 – 9.1 (Ki 8.5x10-10 M) [1-2]
α1A-adrenoceptor Primary target of this compound Hs Antagonist Antagonist 7.9 – 8.7 pKi - 1-2
pKi 7.9 – 8.7 (Ki 2x10-9 M) [1-2]
α1B-adrenoceptor Primary target of this compound Hs Antagonist Antagonist 8.0 – 8.6 pKi - 1-2
pKi 8.0 – 8.6 [1-2]
Ligand mentioned in the following text fields